Maryland Capital Management Care Dx, Inc. Transaction History

Maryland Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$28.19 - $46.6 $143,599 - $237,380	-5,094 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$41.2 - $73.6 $24,060 - $42,982	584 Added 12.95%	5,094 $232,000
Q3 2021 Nov 12, 2021	BUY	$59.15 - $91.99 $4,022 - $6,255	68 Added 1.53%	4,510 $286,000
Q2 2021 Aug 13, 2021	SELL	$63.02 - $95.11 $61,696 - $93,112	-979 Reduced 18.06%	4,442 $407,000
Q1 2021 May 11, 2021	BUY	$57.62 - $95.6 $312,358 - $518,247	5,421 New	5,421 $369,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

Stay updated on Maryland Capital Management with notifications on news.